Simultaneous pancreas-kidney transplantation in a single center: 10-year retrospective analysis / 中华医学杂志(英文版)
Chinese Medical Journal
;
(24): 683-686, 2011.
Article
in English
| WPRIM
| ID: wpr-321438
ABSTRACT
<p><b>BACKGROUND</b>Simultaneous pancreas-kidney transplantation (SPKT) is the best treatment option for diabetic patients with advanced chronic renal failure. The current study aimed to analyze the surgical indications, treatments and prognosis of SPKT.</p><p><b>METHODS</b>We retrospectively analyzed 40 cases of SPKT performed between December 1999 and January 2010 in our center, including the survival rate, complications and the reasons of reoperation.</p><p><b>RESULTS</b>Of all the 40 SPKT cases, the one-year survival rates of the recipients, kidney and pancreas transplant graft were 97.6%, 97.6% and 92.7%, while 97.6%, 91.1%, 92.7% at 3 years and 83.6%, 78.0%, 79.4% at 5 years, respectively. After SPKT, 10 patients need reoperation because of surgical complications (14 operations). The reoperation rate was 25%, including 2 patients (4 operations) with hematuria, 4 patients with abdominal hemorrhage, 2 patients (3 operations) with abdominal infection, 1 patient with pancreatic venous thrombosis, 1 patient with anastomotic leakage, and 1 patient with fistula.</p><p><b>CONCLUSION</b>Although SPKT provides a successful and effective treatment for diabetics with end-stage renal disease, how to reduce the complications of this treatment still need further effort.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Cephalosporins
/
Retrospective Studies
/
Kidney Transplantation
/
Pancreas Transplantation
/
Treatment Outcome
/
Therapeutic Uses
/
Metronidazole
/
Anti-Bacterial Agents
Type of study:
Observational study
Limits:
Adolescent
/
Adult
/
Aged
/
Child
/
Female
/
Humans
/
Male
Language:
English
Journal:
Chinese Medical Journal
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS